Intranasal scopolamine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Intranasal scopolamine, covering 2024-05-16 to 2024-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance [Phase 2]